Helena Aicher

University Hospital Basel / Psychiatric University Hospital Zurich

Speaking at TAIP 2026

Switzerland's compassionate-use framework for psychedelics — patient selection and ethical considerations

Postdoctoral researcher studying ayahuasca-inspired DMT/harmine formulations, including a controlled trial of the combination's effects in healthy subjects. An active member of the Swiss Medical Association for Psycholytic Therapy (SÄPT), which trains therapists working under Switzerland's Article 8 exceptional-use framework — the case-by-case legal pathway that's treated roughly 775 patients since 2014.

Profile

Related on Altitude

Encyclopedia: Ayahuasca
Our coverage: Switzerland's compassionate-use framework

← Back to Conference Speakers